Bellevue Group’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.08M | Buy |
19,472
+1,850
| +10% | +$102K | 0.02% | 103 |
|
|
2025
Q1 | $852K | Sell |
17,622
-6,096
| -26% | -$295K | 0.02% | 109 |
|
|
2024
Q4 | $916K | Buy |
23,718
+11,372
| +92% | +$439K | 0.02% | 119 |
|
|
2024
Q3 | $556K | Sell |
12,346
-2,800
| -18% | -$126K | 0.01% | 126 |
|
|
2024
Q2 | $525K | Sell |
15,146
-4,000
| -21% | -$139K | 0.01% | 128 |
|
|
2024
Q1 | $554K | Sell |
19,146
-10,854
| -36% | -$314K | 0.01% | 127 |
|
|
2023
Q4 | $688K | Hold |
30,000
| – | – | 0.01% | 127 |
|
|
2023
Q3 | $500K | Buy |
+30,000
| New | +$500K | 0.01% | 141 |
|